Lv11
38 积分 2021-11-25 加入
Engineering platelets as cancer therapeutics
7小时前
待确认
Opportunities and challenges of targeting cGAS–STING in cancer
1个月前
已完结
Stochasticity in cancer immunotherapy stems from rare but functionally critical Spark T cells
3个月前
已完结
Ferritin aggregation cell engager for CAR T avidity engineering against refractory leukemias
3个月前
已完结
Agonists for cytosolic bacterial receptor ALPK1 induce antitumour immunity
4个月前
已完结
HMPL-306 in relapsed or refractory IDH1- and/or IDH2-mutated acute myeloid leukemia: A phase 1 study
5个月前
已完结
Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease
6个月前
已完结
Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans
6个月前
已关闭
皖公网安备34019202002308
